United States Dialysis Market Expands Rapidly at 5.8% CAGR on Every Ounce of Renal Innovation Surge - $44 Billion Milestone by 2031, Led by Fresenius Medical Care and DaVita as Top Competitors | DataM Intelligence

Leander, Texas and TOKYO, Japan - Nov. 25, 2025. According to DataM Intelligence, the United States Dialysis Market Size is expected to grow from USD 28.0 billion in 2023 to USD 44.0 billion by 2031, registering a robust CAGR of 5.8% during 2024-2031. The surging demand for advanced renal therapies, the expansion of home-based dialysis options, and advancements in portable hemodialysis technologies are fueling the need for enhanced dialysis systems that maximise patient mobility without compromising treatment efficacy. Dialysis, the life-sustaining process for managing end-stage renal disease through blood filtration, revolutionises chronic kidney care by integrating seamlessly into hospital, clinic, and home care settings, mitigating complications like infections and cardiovascular risks while ensuring compliance with FDA and CMS standards across sectors like nephrology services, equipment manufacturing, and remote monitoring solutions. By combining AI-enabled machines, biocompatible consumables, and precision fluid management processes, this market offers reliable and efficient solutions for hypertension control, electrolyte balance, and quality-of-life enhancement throughout the United States and beyond.

Download PDF Brochure: https://www.datamintelligence.com/download-sample/dialysis-market?Nitin
Explore the comprehensive Table of Contents for the Dialysis Market, featuring:
✅60 Tables
✅50 Figures
✅190 Pages of detailed insights and forecasts

Competitive Landscape

The market is highly competitive among global renal care leaders, equipment innovators, and service providers.

1️⃣Fresenius Medical Care AG expanded its US home dialysis network in Texas, operational since early 2025, enhancing access for over 5,000 patients with 25% improved adherence rates through integrated telehealth.

2️⃣DaVita Inc. acquired a regional nephrology group in California, bolstering its West Coast operations and reporting a 15% revenue uplift in in-centre hemodialysis services.

3️⃣Baxter International Inc. partnered with four telehealth platforms to deploy portable PD systems for rural applications, achieving 90% uptime and capturing 30% of home therapy installations.

4️⃣B. Braun Medical Inc. introduced AI-optimised hemodialysis variants with enhanced biocompatibility, securing contracts with major US hospital chains and driving 20% growth in equipment sales.

5️⃣Medtronic plc rolled out remote monitoring-enabled dialysis consumables for e-clinic integration, reducing readmission rates by 35% and collaborating with payer networks for value-based care models.

Recent Developments

1. Fresenius Medical Care AG acquired MedTech Solutions in March 2024, a specialist in dialysis monitoring tech, as highlighted by nephrologist Dr. Sarah Kline in a Kidney International review, noting its potential to cut treatment costs by 18% through predictive analytics.

2. DaVita Inc. launched an expanded home hemodialysis program in partnership with CMS in July 2024, targeting 10,000 new users, with Bloomberg analyst Mark Rivera praising the initiative for addressing urban-rural disparities in access.

3. Baxter International Inc. unveiled a next-gen peritoneal dialysis cycler with cloud connectivity at the ASN Kidney Week 2024 in Chicago (October 2024), backed by a University of Michigan study showing 22% better fluid balance outcomes.

4. B. Braun Medical Inc. debuted biocompatible dialyser membranes for high-risk patients, collaborating with VA hospitals in May 2025, where Forbes health contributor Dr. Elena Torres emphasised their 28% reduction in inflammation markers.

5. Medtronic plc integrated AI diagnostics into dialysis services for sepsis prevention, slashing complication rates by 40% in pilot trials across Florida centers (February 2025), as endorsed by renal expert Dr. Raj Patel in a JAMA Nephrology commentary.

Request for Customised Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/dialysis-market?Nitin

Growth Drivers

✦ The global renal care market exceeded USD 120 billion in 2024, with dialysis comprising 82% of ESRD treatments, emphasizing the push for portable solutions amid rising CKD prevalence.

✦ US nephrology services surpassed USD 50 billion in 2024, propelling over 550,000 annual dialysis initiations and accelerating adoption for integrated chronic disease management.

✦ Healthcare policies drove USD 350 billion in medtech investments by 2025, prioritising AI-enhanced dialysis that aligns with FDA device approvals and patient outcome transparency.

✦ North American ESRD incidences rose 12% recently, utilising more than 70 million treatment sessions yearly as aging demographics fuel demand for home care transitions.

✦ Technological innovations lowered operational costs by 20%, projecting USD 180 million in annual efficiencies for US providers by 2030 via remote monitoring and automation.

Market Segmentation Analysis

By Type: Hemodialysis dominates with a 82% market share, valued at USD 22.96 billion in 2023 and projected to grow to USD 36.08 billion by 2031 at a 5.8% CAGR. Peritoneal dialysis holds 18% of the market, valued at USD 5.04 billion in 2023 and expected to reach USD 7.92 billion by 2031 at a 5.8% CAGR. The hemodialysis segment's growth is driven by increasing preference for in-center efficiency and technological upgrades compliant with CMS reimbursement guidelines, while peritoneal sustains momentum through home-based accessibility in diverse patient profiles.

By Product: Equipment leads with a commanding 62% market share, valued at USD 17.36 billion in 2023 and forecasted to reach USD 27.28 billion by 2031, favoured for portability and AI integration. Consumables hold 25% share, worth USD 7.0 billion in 2023 and projected to grow to USD 11.0 billion by 2031, attracting providers seeking cost-effective disposables. Services account for the remaining 13%, growing fastest at 6.0% CAGR to USD 5.72 billion by 2031, catering to niche demands for training and maintenance in expanding homecare networks.

By End-User: Dialysis centers constitute the largest segment with 50% market share, valued at USD 14.0 billion in 2023 and expected to expand to USD 22.0 billion by 2031, powered by volume-driven operations and regulatory support. Hospitals hold 30% share, valued at USD 8.4 billion in 2023 and projected to reach USD 13.2 billion by 2031, fueled by acute care integrations. Homecare and others each account for 10% of the market, reflecting growing awareness of flexible therapies and targeted reimbursement incentives for outpatient shifts.

🌍Regional Insights

United States (North America): The U.S. dialysis market was valued at USD 28.0 billion in 2023, projected to reach USD 44.0 billion by 2031 at a 5.8% CAGR. It holds nearly 40% of the global market share, driven by high ESRD rates and robust Medicare coverage. Key players like Fresenius and DaVita lead through service expansions, innovative devices, and nationwide clinics. Adoption of home therapies and digital monitoring strengthens its position. Recent acquisitions and program launches keep the U.S. as the global market leader.

Canada (North America): Canada's market size was USD 3.5 billion in 2023, expected to grow to USD 5.5 billion by 2031 at a 5.7% CAGR, holding roughly 8% of the global market share. Growth is fueled by provincial health funding and regulatory support that boost home dialysis demand. Leading U.S. firms are investing in cross-border tech transfers, accelerating sector maturity. Patient preference for convenient, tech-enabled care continues to rise. Canada complements U.S. leadership with a strong adjacent presence.

Europe (Key countries: UK, Germany, France): Europe constitutes 25% of the global dialysis market and is steadily growing due to harmonised EU directives and rising CKD awareness. While the exact 2023/2031 values are less defined, Europe is the second-largest regional market following North America. The UK, Germany, and France drive expansion through advanced PD solutions and public health campaigns. Market growth is supported by established reimbursement systems and the entry of North American innovators. Europe's progressive policies and broadening patient base make it a crucial growth region.

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50%
OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=dialysis-market

Innovation and Consumer Trends Fueling Market Expansion

Manufacturers are investing heavily in advanced renal technologies, such as AI-driven monitoring and wearable dialyzers, to improve outcomes, reduce complication costs by an estimated 20%, and comply with regulatory standards. Patient growth is driven by expanding knowledge of ESRD prevention, incorporation into personalized care plans, and education on home-based options. North American markets, particularly the U.S., exhibit the highest adoption rates, supported by clinical trials, payer partnerships, and evidence-based therapy blends.

Market Outlook and Opportunities: The Global dialysis market is at a tipping point, driven by demographic pressures and every ounce of engineering evolution in renal devices. Valued at USD 98.05 billion in 2023, it is projected to reach USD 167.0 billion by 2031 at a steady 6.9% CAGR. North America, capturing nearly 40% of the global share, spearheads expansion powered by service demands, while Asia Pacific benefits from population growth. Progress in home portability and biocompatibility aligns with FDA accessibility goals, although hurdles like reimbursement variability, infection controls, and device durability remain. Post-pandemic focus on resilient care and rising uptake of telehealth integrations and customized regimens unlock vast potential for vascular access management and lifestyle enhancement in hospitals, clinics, and homecare sectors.

Related Reports:

Hemodialysis Market -
https://www.datamintelligence.com/research-report/hemodialysis-market?Nitin

Peritoneal Dialysis Market -
https://www.datamintelligence.com/research-report/peritoneal-dialysis-market?Nitin

Chronic Kidney Disease Drugs Market -
https://www.datamintelligence.com/research-report/chronic-kidney-disease-drugs-market?Nitin

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence

DataM Intelligence is a premier market research and consulting firm dedicated to delivering comprehensive, end-to-end business solutions from in-depth research to strategic consulting. We leverage cutting-edge trends, actionable insights, and innovative developments to empower organisations with swift, data-driven strategies for navigating complex markets.

Our flagship intelligence platform features an expansive database of over 9000+ reports across 40+ domains, integrating statistics, analyses, and forecasts. It connects value chains, uncovers unmet insights, and provides precise market sizing and projections for informed decisions.

Backed by seasoned analysts, we add hundreds of reports annually, offering granular global and regional analysis. Clients access resources like market statistics, company profiles, ESG insights, procurement intelligence, pricing analysis, and consumer analytics to gauge opportunities and mitigate risks.

For more updates, follow us on:
Facebook: https://www.facebook.com/datam.intelligence.5/
LinkedIn: https://www.linkedin.com/company/datam-intelligence/
X: https://x.com/DataM_Research
Blog: https://www.datamintelligence.com/blogs

This release was published on openPR.